Review
doi: 10.1038/ajg.2010.445.
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use
Collaborators
- PMID: 21131924
- DOI: 10.1038/ajg.2010.445
Item in Clipboard
Review
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use
Am J Gastroenterol.
2010 Dec.
No abstract available
Similar articles
-
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.Circulation. 2010 Dec 14;122(24):2619-33. doi: 10.1161/CIR.0b013e318202f701. Epub 2010 Nov 8. Circulation. 2010. PMID: 21060077 Review. No abstract available.
-
[Oral antiplatelet agents can still be used along with proton pump inhibitors in spite of drug interactions].Ugeskr Laeger. 2013 Sep 9;175(37):2094-8. Ugeskr Laeger. 2013. PMID: 24011204 Review. Danish.
-
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.J Am Coll Cardiol. 2010 Dec 7;56(24):2051-66. doi: 10.1016/j.jacc.2010.09.010. J Am Coll Cardiol. 2010. PMID: 21126648 No abstract available.
-
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.J Am Coll Cardiol. 2008 Oct 28;52(18):1502-17. doi: 10.1016/j.jacc.2008.08.002. J Am Coll Cardiol. 2008. PMID: 19017521 No abstract available.
-
Risk of combining PPIs with thienopyridines: fact or fiction?Lancet. 2009 Sep 19;374(9694):952-954. doi: 10.1016/S0140-6736(09)61562-2. Epub 2009 Aug 31. Lancet. 2009. PMID: 19726077 No abstract available.
Cited by
-
The risks of PPI therapy.Nat Rev Gastroenterol Hepatol. 2012 Feb 14;9(3):132-9. doi: 10.1038/nrgastro.2011.272. Nat Rev Gastroenterol Hepatol. 2012. PMID: 22330810 Review.
-
Hospital physicians' influence on gastrointestinal protection during treatment with non-steroidal anti-inflammatory drugs and acetylsalicylic acid and the impact on prescribing in primary care.PLoS One. 2013 Dec 6;8(12):e81845. doi: 10.1371/journal.pone.0081845. eCollection 2013. PLoS One. 2013. PMID: 24349137 Free PMC article.
-
Barriers to Guideline-Based Use of Proton Pump Inhibitors to Prevent Upper Gastrointestinal Bleeding.Ann Fam Med. 2022 Jan-Feb;20(1):5-11. doi: 10.1370/afm.2734. Ann Fam Med. 2022. PMID: 35074761 Free PMC article.
-
Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring serum pepsinogen in H. pylori-infected subjects.J Gastroenterol. 2015 Mar;50(3):305-12. doi: 10.1007/s00535-014-0976-5. Epub 2014 Jun 22. J Gastroenterol. 2015. PMID: 24952898
-
Proton pump inhibitor therapy did not increase the prevalence of small-bowel injury: A propensity-matched analysis.PLoS One. 2017 Aug 3;12(8):e0182586. doi: 10.1371/journal.pone.0182586. eCollection 2017. PLoS One. 2017. PMID: 28771618 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
